Selected research
Industry Research
Bromhexine Industry Research Report 2026
Market perspective
The global Bromhexine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Bromhexine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Bromhexine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Bromhexine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Bromhexine include Abbott, Takeda, Wanbangde Pharmaceutical Group, Teva, Shijiazhuang No.4 Pharmaceutical, Shanghai Xudong Haipu Pharmaceutical, Shanghai Sine Tianping Pharmaceutical, Shanxi Powerdone Pharmaceutical and Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Bromhexine market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bromhexine Market by Company
Abbott
Takeda
Wanbangde Pharmaceutical Group
Teva
Shijiazhuang No.4 Pharmaceutical
Shanghai Xudong Haipu Pharmaceutical
Shanghai Sine Tianping Pharmaceutical
Shanxi Powerdone Pharmaceutical
Sandoz
Shanxi Powerdone Pharmaceutical
Novartis
Mylan
Jincheng Haisi Pharmaceutical
GSK
Sigma-Aldrich
Sanyo Chemical Laboratroy
Sanofi Aventis
Mayne Pharma
Ma'AnShan BBCA Pharmaceutical
LGM Pharma
Boehringer Ingelheim
Bromhexine Segment by Type
Oral
Injection
Bromhexine Segment by Application
Chronic Bronchitis
Asthma
Others
Bromhexine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bromhexine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bromhexine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bromhexine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bromhexine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bromhexine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bromhexine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Injection
Applications
- Chronic Bronchitis
- Asthma
- Others
Companies covered
- Abbott
- Takeda
- Wanbangde Pharmaceutical Group
- Teva
- Shijiazhuang No.4 Pharmaceutical
- Shanghai Xudong Haipu Pharmaceutical
- Shanghai Sine Tianping Pharmaceutical
- Shanxi Powerdone Pharmaceutical
- Sandoz
- Shanxi Powerdone Pharmaceutical
- Novartis
- Mylan
- Jincheng Haisi Pharmaceutical
- GSK
- Sigma-Aldrich
- Sanyo Chemical Laboratroy
- Sanofi Aventis
- Mayne Pharma
- Ma'AnShan BBCA Pharmaceutical
- LGM Pharma
- Boehringer Ingelheim
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Bromhexine Market Size (2021-2032)
- 2.2.2 Global Bromhexine Sales (2021-2032)
- 2.2.3 Global Bromhexine Market Average Price (2021-2032)
- 2.3 Bromhexine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral
- 2.3.3 Injection
- 2.4 Bromhexine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Chronic Bronchitis
- 2.4.3 Asthma
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bromhexine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Bromhexine Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Bromhexine Revenue of Manufacturers (2021-2026)
- 3.4 Global Bromhexine Average Price by Manufacturers (2021-2026)
- 3.5 Global Bromhexine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Bromhexine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Bromhexine, Product Type & Application
- 3.8 Global Manufacturers of Bromhexine, Established Date
- 3.9 Global Bromhexine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Company Information
- 4.1.2 Abbott Business Overview
- 4.1.3 Abbott Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Bromhexine Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 Takeda
- 4.2.1 Takeda Company Information
- 4.2.2 Takeda Business Overview
- 4.2.3 Takeda Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Takeda Bromhexine Product Portfolio
- 4.2.5 Takeda Recent Developments
- 4.3 Wanbangde Pharmaceutical Group
- 4.3.1 Wanbangde Pharmaceutical Group Company Information
- 4.3.2 Wanbangde Pharmaceutical Group Business Overview
- 4.3.3 Wanbangde Pharmaceutical Group Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Wanbangde Pharmaceutical Group Bromhexine Product Portfolio
- 4.3.5 Wanbangde Pharmaceutical Group Recent Developments
- 4.4 Teva
- 4.4.1 Teva Company Information
- 4.4.2 Teva Business Overview
- 4.4.3 Teva Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Teva Bromhexine Product Portfolio
- 4.4.5 Teva Recent Developments
- 4.5 Shijiazhuang No.4 Pharmaceutical
- 4.5.1 Shijiazhuang No.4 Pharmaceutical Company Information
- 4.5.2 Shijiazhuang No.4 Pharmaceutical Business Overview
- 4.5.3 Shijiazhuang No.4 Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shijiazhuang No.4 Pharmaceutical Bromhexine Product Portfolio
- 4.5.5 Shijiazhuang No.4 Pharmaceutical Recent Developments
- 4.6 Shanghai Xudong Haipu Pharmaceutical
- 4.6.1 Shanghai Xudong Haipu Pharmaceutical Company Information
- 4.6.2 Shanghai Xudong Haipu Pharmaceutical Business Overview
- 4.6.3 Shanghai Xudong Haipu Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shanghai Xudong Haipu Pharmaceutical Bromhexine Product Portfolio
- 4.6.5 Shanghai Xudong Haipu Pharmaceutical Recent Developments
- 4.7 Shanghai Sine Tianping Pharmaceutical
- 4.7.1 Shanghai Sine Tianping Pharmaceutical Company Information
- 4.7.2 Shanghai Sine Tianping Pharmaceutical Business Overview
- 4.7.3 Shanghai Sine Tianping Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Shanghai Sine Tianping Pharmaceutical Bromhexine Product Portfolio
- 4.7.5 Shanghai Sine Tianping Pharmaceutical Recent Developments
- 4.8 Shanxi Powerdone Pharmaceutical
- 4.8.1 Shanxi Powerdone Pharmaceutical Company Information
- 4.8.2 Shanxi Powerdone Pharmaceutical Business Overview
- 4.8.3 Shanxi Powerdone Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shanxi Powerdone Pharmaceutical Bromhexine Product Portfolio
- 4.8.5 Shanxi Powerdone Pharmaceutical Recent Developments
- 4.9 Sandoz
- 4.9.1 Sandoz Company Information
- 4.9.2 Sandoz Business Overview
- 4.9.3 Sandoz Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sandoz Bromhexine Product Portfolio
- 4.9.5 Sandoz Recent Developments
- 4.10 Shanxi Powerdone Pharmaceutical
- 4.10.1 Shanxi Powerdone Pharmaceutical Company Information
- 4.10.2 Shanxi Powerdone Pharmaceutical Business Overview
- 4.10.3 Shanxi Powerdone Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Shanxi Powerdone Pharmaceutical Bromhexine Product Portfolio
- 4.10.5 Shanxi Powerdone Pharmaceutical Recent Developments
- 4.11 Novartis
- 4.11.1 Novartis Company Information
- 4.11.2 Novartis Business Overview
- 4.11.3 Novartis Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Novartis Bromhexine Product Portfolio
- 4.11.5 Novartis Recent Developments
- 4.12 Mylan
- 4.12.1 Mylan Company Information
- 4.12.2 Mylan Business Overview
- 4.12.3 Mylan Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Mylan Bromhexine Product Portfolio
- 4.12.5 Mylan Recent Developments
- 4.13 Jincheng Haisi Pharmaceutical
- 4.13.1 Jincheng Haisi Pharmaceutical Company Information
- 4.13.2 Jincheng Haisi Pharmaceutical Business Overview
- 4.13.3 Jincheng Haisi Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Jincheng Haisi Pharmaceutical Bromhexine Product Portfolio
- 4.13.5 Jincheng Haisi Pharmaceutical Recent Developments
- 4.14 GSK
- 4.14.1 GSK Company Information
- 4.14.2 GSK Business Overview
- 4.14.3 GSK Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 GSK Bromhexine Product Portfolio
- 4.14.5 GSK Recent Developments
- 4.15 Sigma-Aldrich
- 4.15.1 Sigma-Aldrich Company Information
- 4.15.2 Sigma-Aldrich Business Overview
- 4.15.3 Sigma-Aldrich Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Sigma-Aldrich Bromhexine Product Portfolio
- 4.15.5 Sigma-Aldrich Recent Developments
- 4.16 Sanyo Chemical Laboratroy
- 4.16.1 Sanyo Chemical Laboratroy Company Information
- 4.16.2 Sanyo Chemical Laboratroy Business Overview
- 4.16.3 Sanyo Chemical Laboratroy Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Sanyo Chemical Laboratroy Bromhexine Product Portfolio
- 4.16.5 Sanyo Chemical Laboratroy Recent Developments
- 4.17 Sanofi Aventis
- 4.17.1 Sanofi Aventis Company Information
- 4.17.2 Sanofi Aventis Business Overview
- 4.17.3 Sanofi Aventis Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Sanofi Aventis Bromhexine Product Portfolio
- 4.17.5 Sanofi Aventis Recent Developments
- 4.18 Mayne Pharma
- 4.18.1 Mayne Pharma Company Information
- 4.18.2 Mayne Pharma Business Overview
- 4.18.3 Mayne Pharma Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Mayne Pharma Bromhexine Product Portfolio
- 4.18.5 Mayne Pharma Recent Developments
- 4.19 Ma'AnShan BBCA Pharmaceutical
- 4.19.1 Ma'AnShan BBCA Pharmaceutical Company Information
- 4.19.2 Ma'AnShan BBCA Pharmaceutical Business Overview
- 4.19.3 Ma'AnShan BBCA Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Ma'AnShan BBCA Pharmaceutical Bromhexine Product Portfolio
- 4.19.5 Ma'AnShan BBCA Pharmaceutical Recent Developments
- 4.20 LGM Pharma
- 4.20.1 LGM Pharma Company Information
- 4.20.2 LGM Pharma Business Overview
- 4.20.3 LGM Pharma Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 LGM Pharma Bromhexine Product Portfolio
- 4.20.5 LGM Pharma Recent Developments
- 4.21 Boehringer Ingelheim
- 4.21.1 Boehringer Ingelheim Company Information
- 4.21.2 Boehringer Ingelheim Business Overview
- 4.21.3 Boehringer Ingelheim Bromhexine Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 Boehringer Ingelheim Bromhexine Product Portfolio
- 4.21.5 Boehringer Ingelheim Recent Developments
5 Global Bromhexine Market Scenario by Region
- 5.1 Global Bromhexine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bromhexine Sales by Region: 2021-2032
- 5.2.1 Global Bromhexine Sales by Region: 2021-2026
- 5.2.2 Global Bromhexine Sales by Region: 2027-2032
- 5.3 Global Bromhexine Revenue by Region: 2021-2032
- 5.3.1 Global Bromhexine Revenue by Region: 2021-2026
- 5.3.2 Global Bromhexine Revenue by Region: 2027-2032
- 5.4 North America Bromhexine Market Facts & Figures by Country
- 5.4.1 North America Bromhexine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Bromhexine Sales by Country (2021-2032)
- 5.4.3 North America Bromhexine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Bromhexine Market Facts & Figures by Country
- 5.5.1 Europe Bromhexine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Bromhexine Sales by Country (2021-2032)
- 5.5.3 Europe Bromhexine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Bromhexine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Bromhexine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Bromhexine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Bromhexine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Bromhexine Market Facts & Figures by Country
- 5.7.1 South America Bromhexine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Bromhexine Sales by Country (2021-2032)
- 5.7.3 South America Bromhexine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Bromhexine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Bromhexine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Bromhexine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Bromhexine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Bromhexine Sales by Type (2021-2032)
- 6.1.1 Global Bromhexine Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Bromhexine Sales Market Share by Type (2021-2032)
- 6.2 Global Bromhexine Revenue by Type (2021-2032)
- 6.2.1 Global Bromhexine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Bromhexine Revenue Market Share by Type (2021-2032)
- 6.3 Global Bromhexine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Bromhexine Sales by Application (2021-2032)
- 7.1.1 Global Bromhexine Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Bromhexine Sales Market Share by Application (2021-2032)
- 7.2 Global Bromhexine Revenue by Application (2021-2032)
- 7.2.1 Global Bromhexine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Bromhexine Revenue Market Share by Application (2021-2032)
- 7.3 Global Bromhexine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Bromhexine Value Chain Analysis
- 8.1.1 Bromhexine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Bromhexine Production Mode & Process
- 8.2 Bromhexine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Bromhexine Distributors
- 8.2.3 Bromhexine Customers
9 Global Bromhexine Analyzing Market Dynamics
- 9.1 Bromhexine Industry Trends
- 9.2 Bromhexine Industry Drivers
- 9.3 Bromhexine Industry Opportunities and Challenges
- 9.4 Bromhexine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst